Inside Nicotine-Pouch M&A Through Imperial's Yoik Deal: Latham, KPMG, PwC, Goldman Sachs and Morgan Stanley Form the Adviser Lineup

Sep.20
Inside Nicotine-Pouch M&A Through Imperial's Yoik Deal: Latham, KPMG, PwC, Goldman Sachs and Morgan Stanley Form the Adviser Lineup
Imperial Brands' acquisition of Swedish Helwit owner Yoik Group AB has highlighted the professional-services firms supporting cross-border oral nicotine M&A. Latham & Watkins and KPMG advised Imperial, while PwC and TM & Partners advised Yoik. KPMG also appeared on Imperial's acquisition of Black Buffalo earlier in 2026, while PwC played an extensive role in KT&G's acquisition of Swedish nicotine-pouch company Another Snus Factory. Imperial's public disclosures put the global modern oral nicotine delivery market at approximately £8.8 billion in retail sales and 23.5 billion pouches in 2024

Key Points

  • Imperial acquired 100% of Yoik for an initial SEK 515 million, with Latham & Watkins and KPMG on the buyer side and PwC and TM & Partners advising Yoik.
  • KPMG also advised Imperial on its 2026 acquisition of Black Buffalo, making it the recurring adviser across Imperial's two disclosed modern oral acquisitions this year.
  • Imperial's Black Buffalo deal also involved Morgan Stanley and White & Case for the buyer, with Goldman Sachs and Paul, Weiss advising the seller.
  • PwC supported KT&G's acquisition of Another Snus Factory from target screening through due diligence, structuring, negotiations and closing, and later appeared among the advisers to Yoik.
  • Imperial data citing Euromonitor put the global modern oral nicotine delivery category at around 23.5 billion pouches and £8.8 billion in retail sales in 2024.

2Firsts

September 20, 2026

Imperial Brands' September acquisition of Swedish modern oral nicotine company Yoik Group AB has disclosed a broader lineup of professional-services firms working across the transaction.

Imperial acquired 100% of Yoik for an initial SEK 515 million, or approximately £39.8 million, with an additional deferred payment linked to performance over the following two years.

Yoik's Helwit brand held about 3.4% of Sweden's modern oral market over the previous 12 months. Imperial said the deal would more than double its existing share of the category in Sweden, which represents more than 40% of European modern oral nicotine volumes.

Imperial was advised by Latham & Watkins and KPMG, while Yoik was advised by PwC and TM & Partners.

Latham and KPMG Join Imperial's Yoik Adviser Team

Latham said its London corporate team led the Yoik transaction, supported by lawyers covering tax, employment, data and technology transactions, regulatory matters, antitrust, sanctions, ESG and real estate.

The firm's publicly disclosed work for Imperial extends beyond the acquisition. Imperial's 2026 global medium-term note prospectus also names Latham & Watkins as legal adviser to the issuers and guarantor on English and U.S. law.

KPMG, meanwhile, also appeared in another Imperial modern oral transaction earlier this year.

In May, Imperial acquired U.S. modern oral company Black Buffalo. The buyer was advised by Morgan Stanley, KPMG and White & Case, while Black Buffalo was advised by Goldman Sachs and Paul, Weiss.

Black Buffalo sells long-cut and pouch products aimed primarily at adult users of traditional moist smokeless tobacco. Its product positioning is therefore not identical to a nicotine-pouch brand such as Helwit, making the two transactions more appropriately comparable as part of Imperial's broader modern oral expansion.

KPMG Appears in Both Imperial Modern Oral Acquisitions

Across Imperial's publicly disclosed Black Buffalo and Yoik acquisitions in 2026, the law firms and investment banks changed while KPMG appeared on the buyer side of both transactions.

TransactionAsset / BrandMarketBuyerBuyer AdvisersSeller Advisers
Yoik Group / HelwitNicotine pouchesSwedenImperial BrandsLatham & Watkins, KPMGPwC, TM & Partners
Black BuffaloModern oralU.S.Imperial BrandsMorgan Stanley, KPMG, White & CaseGoldman Sachs, Paul, Weiss
Another Snus Factory / LOOPNicotine pouchesSwedenKT&G acquisition, with an Altria subsidiary taking an equity interestPwC provided buy-side support to KT&GNot fully disclosed in the public materials reviewed

Imperial's acquisition announcements do not specify whether KPMG's work covered financial due diligence, tax, valuation or another advisory function.

The firm's presence in both transactions nevertheless makes it the recurring external adviser identified across Imperial's two disclosed modern oral acquisitions in 2026.

PwC Supports ASF Deal From Target Screening to Closing

PwC appears on the seller side of the Yoik transaction, while its work on another Swedish nicotine-pouch acquisition was broader.

In 2025, KT&G acquired Swedish nicotine-pouch company Another Snus Factory, with an Altria subsidiary taking an equity interest under the companies' investment arrangement. ASF owns the LOOP brand.

PwC said its Korean team became involved early in KT&G's process, reviewing a range of NGP businesses across Europe and identifying ASF as an acquisition target.

After target identification, PwC's work covered acquisition strategy, due diligence, transaction structuring, negotiations and closing, with teams in Korea and Sweden working on the transaction.

PwC also said the process involved a competitive bidding environment with several global investors, while multiple global tobacco companies had been considered as potential co-investors.

PwC therefore appears in at least two transactions involving Swedish nicotine-pouch assets: on the buy side for KT&G's ASF transaction and among the seller advisers in Yoik's sale to Imperial.

Global Modern Oral Retail Sales Reached About £8.8 Billion in 2024

The acquisitions are taking place in a category that has developed into a multibillion-pound consumer market.

Imperial's 2026 global medium-term note prospectus, citing Euromonitor data, said approximately 23.5 billion modern oral nicotine delivery pouches were sold globally in 2024, representing an estimated £8.8 billion in retail sales.

The largest markets by category value included:

  • the United States at approximately £6.9 billion;
  • Sweden and Denmark combined at approximately £0.8 billion.

The figures show that category value remains heavily concentrated in a small number of markets, led by the United States, while Sweden is the largest modern oral market in Europe.

Imperial also said most category growth over the next several years is expected to come from the U.S.

Cross-Border Deals Use Different Adviser Combinations

The Black Buffalo, Yoik and ASF transactions used different combinations of external advisers.

Imperial's Black Buffalo acquisition brought together international investment banks, a Big Four firm and global law firms. Its Yoik deal paired Latham and KPMG on the buyer side with PwC and Swedish firm TM & Partners for the seller.

The ASF transaction also shows that Big Four involvement in nicotine-pouch M&A can extend beyond conventional due diligence to target screening, acquisition strategy, structuring and negotiations.

Imperial has completed two modern oral acquisitions in 2026 through Black Buffalo and Yoik, while KT&G has expanded into nicotine pouches through ASF. All three transactions involved multiple external professional-services firms.

As nicotine-pouch and modern oral assets become part of the acquisition portfolios of multinational tobacco companies, global law firms, Big Four firms and investment banks are increasingly appearing across the transaction chain.

Follow 2Firsts for timely coverage of global tobacco and nicotine M&A, capital markets and corporate strategy.

Cover Image generated by AI


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

PMI Expands Its Second Global and First Asian Business Services Hub in the Philippines, Serving 160 Markets and Scaling Up AI Capabilities
PMI Expands Its Second Global and First Asian Business Services Hub in the Philippines, Serving 160 Markets and Scaling Up AI Capabilities
Philip Morris International's PMI Business Solutions Philippines has expanded its global business services hub in Makati and plans to add more than 80 positions. Established in 2021 primarily to provide finance and IT support to about 20 markets, the center now employs 519 professionals delivering roughly 600 services across 160 markets. Its functions now span finance, human resources, IT, commercial operations, data analytics, supply chain and project management. PMI says the hub's next phase will focus on AI-enabled and higher-value work. The company did not disclose the size or investment cost of the expansion.
Sep.24
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08
Kelly White Bets on Female Consumers as Nicotine Pouch Competition Intensifies | 2Firsts Interview
Kelly White Bets on Female Consumers as Nicotine Pouch Competition Intensifies | 2Firsts Interview
Swedish nicotine pouch brand Kelly White is building its strategy around adult female consumers. Founder and CEO Sophia Wilsby told 2Firsts that women accounted for around 70% of the brand’s repeat customers on HAYPP in Sweden in 2025. The interview explores female consumer segmentation, product and design differentiation, gender stereotypes, packaging regulation, and how independent brands can compete with global players such as ZYN and VELO while considering funding, partnerships and future ownership options.
Business
Sep.24
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Asia Manufacturing Corp. has invested ₱2.1 billion, or about $37 million, in its manufacturing site in Malvar, Batangas, Philippines, to expand tobacco-processing capabilities. About ₱1.9 billion is allocated to JTI's first Dry Ice Expanded Tobacco, or DIET, facility in Southeast Asia, while more than ₱177 million has been spent on expanding its Controlled Atmosphere treatment facility. The Batangas plant supplies the Philippine market and exports to 22 overseas markets, making it one of JTI's key manufacturing hubs in Asia.
Sep.24
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech launched IKE 2.0 on September 28, initially targeting nicotine products with a platform that combines user identity verification, product authentication, configurable policy controls and data analytics. Products can be authenticated through direct device integration or NFC smart tags. IKE Tech was formed with participation from Ispire's Aspire North America, Berify and Chemular, with Ispire currently holding a 40% interest. Its age-verification component PMTA was accepted by the FDA in 2025 and remains under review. The company did not disclose customer names, commercial deployment volumes, pricing or revenue tied to IKE 2.0.
News
Sep.29 by 2Firsts Perspectives
Special Report | From Oversupply to Supply Gaps: Global Tobacco Leaf Markets Diverge Ahead of 2027
Special Report | From Oversupply to Supply Gaps: Global Tobacco Leaf Markets Diverge Ahead of 2027
Global tobacco leaf markets diverged sharply in 2026, with India cutting authorised FCV production amid oversupply while Malawi faced a supply shortfall. U.S. demand improved in some leaf categories, but growers in Brazil, Colombia, Tanzania and Zimbabwe faced pressure from prices, buyer access, costs and weather. With nicotine consumption patterns also shifting, 2027 will test whether supply, demand and grower profitability can move back toward balance.
Oct.26